Expected Moves

Heightened geopolitical friction and trade rhetoric under the Trump administration targeting Chinese imports and cross-border commerce.

Management's scheduled update on the Infant Milk Formula (IMF) recovery strategy and supply chain transformation.

First-half FY27 financial results, marking the first major progress report on the integrated a2 Pokeno facility.

Progress read-out on the USA growth segment, leveraging recent clinical data on beta-casein digestive benefits.

Full-year FY27 results, offering a definitive scorecard on the multi-year supply chain and margin recovery.